Network pharmacology and molecular docking identify eugenol as a lead compound targeting visceral leishmaniasis pathways with nanotechnology-driven drug design and nanoscale interaction analysis. ETN. 2026;10(3):1449-1468. doi:10.56053/10.3.1449